血脂异常的临床方面。 - Suppr

Suppr

超能文献

Clinical aspects of dyslipidemia.

作者信息

Kashyap M

机构信息

Cholesterol Research Center, Department of Veterans Affairs Healthcare System, Long Beach, Calif., USA.

出版信息

Manag Care. 2001 Nov;10(11 Suppl):4-9; discussion 19-24.

PMID:11761628

Abstract

摘要

相似文献

Clinical aspects of dyslipidemia.

Manag Care. 2001 Nov;10(11 Suppl):4-9; discussion 19-24.

[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].

Dtsch Med Wochenschr. 2005 Sep 30;130(39):2220-5. doi: 10.1055/s-2005-916368.

[Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].

MMW Fortschr Med. 2003 Oct 9;145(41):48.

Changing face of dyslipidemia therapy.

Indian Heart J. 2008 May-Jun;60(3):192-4.

Clinical trials and tribulations. Cholesterol veers off script.

Science. 2008 Oct 10;322(5899):220-3. doi: 10.1126/science.322.5899.220.

The case for medical treatment in chronic stable coronary artery disease.

Arch Intern Med. 2005;165(22):2587-9, discussion 2593-4. doi: 10.1001/archinte.165.22.2587.

The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach.

Cardiovasc Pathol. 2004 May-Jun;13(3):125-38. doi: 10.1016/S1054-8807(04)00004-3.

The power of statins: aggressive lipid lowering.

Postgrad Med. 2002 Oct;112(4 Suppl):23-30. doi: 10.3810/pgm.10.2002.suppl20.108.

Combining niacin with statins: does it help heart health?

Johns Hopkins Med Lett Health After 50. 2011 Dec;23(10):1-2.

Optimal lipids, statins, and dementia.

J Am Coll Cardiol. 2005 Mar 15;45(6):963-4; author reply 964-5. doi: 10.1016/j.jacc.2004.12.019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Clinical aspects of dyslipidemia.

Manag Care. 2001 Nov;10(11 Suppl):4-9; discussion 19-24.

[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].

Dtsch Med Wochenschr. 2005 Sep 30;130(39):2220-5. doi: 10.1055/s-2005-916368.

[Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].

MMW Fortschr Med. 2003 Oct 9;145(41):48.

Changing face of dyslipidemia therapy.

Indian Heart J. 2008 May-Jun;60(3):192-4.

Clinical trials and tribulations. Cholesterol veers off script.

Science. 2008 Oct 10;322(5899):220-3. doi: 10.1126/science.322.5899.220.

The case for medical treatment in chronic stable coronary artery disease.

Arch Intern Med. 2005;165(22):2587-9, discussion 2593-4. doi: 10.1001/archinte.165.22.2587.

The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach.

Cardiovasc Pathol. 2004 May-Jun;13(3):125-38. doi: 10.1016/S1054-8807(04)00004-3.

The power of statins: aggressive lipid lowering.

Postgrad Med. 2002 Oct;112(4 Suppl):23-30. doi: 10.3810/pgm.10.2002.suppl20.108.

Combining niacin with statins: does it help heart health?

Johns Hopkins Med Lett Health After 50. 2011 Dec;23(10):1-2.

Optimal lipids, statins, and dementia.

J Am Coll Cardiol. 2005 Mar 15;45(6):963-4; author reply 964-5. doi: 10.1016/j.jacc.2004.12.019.